Track topics on Twitter Track topics that are important to you
Second Sight Medical Products reported a net loss of $6.8 million, or $0.12 per share, in the second quarter of 2017 compared with a net loss of $8.5 million, or $0.23 per share, in the second quarter of last year, according to a press release.Total revenue increased from $1 million in the second quarter of 2016 to $2.2 million. This was attributed to an increase in implant volume and higher CMS reimbursement in the U.S. in 2017.
Original Article: Second Sight posts lower net loss in second quarterNEXT ARTICLE
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...